• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳低聚糖 3-FL、乳-N-新四糖和 LDFT 通过脱落或与肿瘤坏死因子受体 1 相互作用,体外减轻肿瘤坏死因子-α诱导的胎儿肠道上皮细胞炎症。

The Human Milk Oligosaccharides 3-FL, Lacto-N-Neotetraose, and LDFT Attenuate Tumor Necrosis Factor-α Induced Inflammation in Fetal Intestinal Epithelial Cells In Vitro through Shedding or Interacting with Tumor Necrosis Factor Receptor 1.

机构信息

Immunoendocrinology, Division of Medical Biology, Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, RB, Groningen, 9700, The Netherlands.

Drug Design XB20, Groningen Research Institute of Pharmacy, University of Groningen, AD, Groningen, 9700, The Netherlands.

出版信息

Mol Nutr Food Res. 2021 Apr;65(7):e2000425. doi: 10.1002/mnfr.202000425. Epub 2021 Mar 3.

DOI:10.1002/mnfr.202000425
PMID:33465830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8047892/
Abstract

SCOPE

Human milk oligosaccharides (hMOs) can attenuate inflammation by modulating intestinal epithelial cells, but the mechanisms of action are not well-understood. Here, the effects of hMOs on tumor necrosis factor-α (TNF-α) induced inflammatory events in gut epithelial cells are studied.

METHODS AND RESULTS

The modulatory effects of 2'-fucosyllactose, 3-fucosyllactose (3-FL), 6'-sialyllactose, lacto-N-tetraose, lacto-N-neotetraose (LNnT), lactodifucotetraose (LDFT), and lacto-N-triaose (LNT2) on immature (FHs 74 Int) and adult (T84) intestinal epithelial cells with or without TNF-α are determined. Interleukin-8 (IL-8) secretion in FHs 74 Int and T84 are quantified to determine hMO induced attenuation of inflammatory events by ELISA. 3-FL, LNnT, and LDFT significantly attenuate TNF-α induced inflammation in FHs 74 Int, while LNT2 induces IL-8 secretion in T84. In addition, microscale thermophoresis assays and ELISA are used to study the possible mechanisms of interaction between effective hMOs and tumor necrosis factor receptor 1 (TNFR1). 3-FL, LNnT, and LDFT exert TNFR1 ectodomain shedding while LNnT also shows binding affinity to TNFR1 with a Kd of 900 ± 660 nM.

CONCLUSION

The findings indicate that specific hMO types attenuate TNF-α induced inflammation in fetal gut epithelial cells through TNFR1 in a hMO structure-dependent fashion suggest possibilities to apply hMOs in management of TNF-α dependent diseases.

摘要

范围

人乳寡糖(hMOs)可以通过调节肠道上皮细胞来减轻炎症,但作用机制尚不清楚。本研究旨在研究 hMOs 对肠道上皮细胞中肿瘤坏死因子-α(TNF-α)诱导的炎症事件的影响。

方法和结果

研究了 2'-岩藻糖基乳糖、3-岩藻糖基乳糖(3-FL)、6'-唾液酸乳糖、乳-N-四糖、乳-N-新四糖(LNnT)、乳二岩藻四糖(LDFT)和乳-N-三糖(LNT2)在有无 TNF-α 的情况下对未成熟(FHs 74 Int)和成人(T84)肠道上皮细胞的调节作用。通过 ELISA 定量测定 FHs 74 Int 和 T84 中的白细胞介素-8(IL-8)分泌,以确定 hMO 对炎症事件的抑制作用。3-FL、LNnT 和 LDFT 显著减轻了 FHs 74 Int 中 TNF-α 诱导的炎症,而 LNT2 则诱导了 T84 中 IL-8 的分泌。此外,使用微量热泳动分析和 ELISA 研究了有效 hMO 与肿瘤坏死因子受体 1(TNFR1)之间相互作用的可能机制。3-FL、LNnT 和 LDFT 发挥了 TNFR1 外显肽脱落的作用,而 LNnT 也显示出与 TNFR1 的结合亲和力,Kd 值为 900±660 nM。

结论

研究结果表明,特定的 hMO 类型通过 TNFR1 以 hMO 结构依赖性的方式减轻胎儿肠道上皮细胞中 TNF-α 诱导的炎症,这为应用 hMO 治疗 TNF-α 依赖性疾病提供了可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b827/8047892/3c4af72751f8/MNFR-65-2000425-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b827/8047892/43a53a698a3d/MNFR-65-2000425-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b827/8047892/089d0f9e2af6/MNFR-65-2000425-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b827/8047892/20a201164871/MNFR-65-2000425-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b827/8047892/c10d034ea564/MNFR-65-2000425-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b827/8047892/391753cb9002/MNFR-65-2000425-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b827/8047892/b55905205eea/MNFR-65-2000425-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b827/8047892/3c4af72751f8/MNFR-65-2000425-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b827/8047892/43a53a698a3d/MNFR-65-2000425-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b827/8047892/089d0f9e2af6/MNFR-65-2000425-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b827/8047892/20a201164871/MNFR-65-2000425-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b827/8047892/c10d034ea564/MNFR-65-2000425-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b827/8047892/391753cb9002/MNFR-65-2000425-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b827/8047892/b55905205eea/MNFR-65-2000425-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b827/8047892/3c4af72751f8/MNFR-65-2000425-g004.jpg

相似文献

1
The Human Milk Oligosaccharides 3-FL, Lacto-N-Neotetraose, and LDFT Attenuate Tumor Necrosis Factor-α Induced Inflammation in Fetal Intestinal Epithelial Cells In Vitro through Shedding or Interacting with Tumor Necrosis Factor Receptor 1.人乳低聚糖 3-FL、乳-N-新四糖和 LDFT 通过脱落或与肿瘤坏死因子受体 1 相互作用,体外减轻肿瘤坏死因子-α诱导的胎儿肠道上皮细胞炎症。
Mol Nutr Food Res. 2021 Apr;65(7):e2000425. doi: 10.1002/mnfr.202000425. Epub 2021 Mar 3.
2
Human Milk Oligosaccharides Differently Modulate Goblet Cells Under Homeostatic, Proinflammatory Conditions and ER Stress.人乳寡糖在稳态、炎症前状态和内质网应激下对杯状细胞的调节作用不同。
Mol Nutr Food Res. 2020 Mar;64(5):e1900976. doi: 10.1002/mnfr.201900976. Epub 2019 Dec 11.
3
Human Milk Oligosaccharides and Synthetic Galactosyloligosaccharides Contain 3'-, 4-, and 6'-Galactosyllactose and Attenuate Inflammation in Human T84, NCM-460, and H4 Cells and Intestinal Tissue Ex Vivo.人乳寡糖和合成半乳糖基寡糖含有3'-、4-和6'-半乳糖基乳糖,并可减轻人T84、NCM - 460和H4细胞以及离体肠道组织中的炎症。
J Nutr. 2016 Feb;146(2):358-67. doi: 10.3945/jn.115.220749. Epub 2015 Dec 23.
4
Distinct fermentation of human milk oligosaccharides 3-FL and LNT2 and GOS/inulin by infant gut microbiota and impact on adhesion of WCFS1 to gut epithelial cells.人乳寡糖 3-FL 和 LNT2 以及 GOS/菊粉的不同发酵及对肠道上皮细胞粘附 WCFS1 的影响。
Food Funct. 2021 Dec 13;12(24):12513-12525. doi: 10.1039/d1fo02563e.
5
Human Milk Oligosaccharides Are Associated with Lactation Stage and Lewis Phenotype in a Chinese Population.人乳寡糖与中国人群的泌乳阶段和 Lewis 表型相关。
Nutrients. 2023 Mar 15;15(6):1408. doi: 10.3390/nu15061408.
6
Blends of Human Milk Oligosaccharides Confer Intestinal Epithelial Barrier Protection in Vitro.人乳低聚糖混合物在体外赋予肠道上皮屏障保护作用。
Nutrients. 2020 Oct 5;12(10):3047. doi: 10.3390/nu12103047.
7
Structure-Function Relationships of Human Milk Oligosaccharides on the Intestinal Epithelial Transcriptome in Caco-2 Cells and a Murine Model of Necrotizing Enterocolitis.人乳寡糖对Caco-2细胞和坏死性小肠结肠炎小鼠模型肠道上皮转录组的结构-功能关系
Mol Nutr Food Res. 2022 Feb;66(4):e2100893. doi: 10.1002/mnfr.202100893. Epub 2021 Dec 29.
8
Human Milk Oligosaccharides Mediate the Crosstalk Between Intestinal Epithelial Caco-2 Cells and Lactobacillus PlantarumWCFS1in an In Vitro Model with Intestinal Peristaltic Shear Force.人乳寡糖在具有肠道蠕动剪切力的体外模型中介导肠道上皮 Caco-2 细胞与植物乳杆菌 WCFS1 的串扰。
J Nutr. 2020 Aug 1;150(8):2077-2088. doi: 10.1093/jn/nxaa162.
9
Human Milk Oligosaccharides and Lactose Differentially Affect Infant Gut Microbiota and Intestinal Barrier In Vitro.人乳低聚糖和乳糖对婴儿肠道微生物群和肠道屏障的体外影响不同。
Nutrients. 2022 Jun 19;14(12):2546. doi: 10.3390/nu14122546.
10
Human Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula.人乳寡糖:婴儿配方奶粉中的 2'-岩藻糖基乳糖(2'-FL)和乳-N-新四糖(LNnT)。
Nutrients. 2018 Aug 24;10(9):1161. doi: 10.3390/nu10091161.

引用本文的文献

1
Recent advances in the science of human milk oligosaccharides.人乳寡糖科学的最新进展
BBA Adv. 2025 Jan 24;7:100136. doi: 10.1016/j.bbadva.2024.100136. eCollection 2025.
2
Human milk oligosaccharides: bridging the gap in intestinal microbiota between mothers and infants.人乳寡糖:弥合母婴肠道微生物群之间的差距。
Front Cell Infect Microbiol. 2025 Jan 6;14:1386421. doi: 10.3389/fcimb.2024.1386421. eCollection 2024.
3
Recent advances of 3-fucosyllactose in health effects and production.3-岩藻糖乳糖在健康影响和生产方面的最新进展。

本文引用的文献

1
Relationship Between Oligosaccharides and Glycoconjugates Content in Human Milk and the Development of the Gut Barrier.人乳中寡糖和糖缀合物含量与肠道屏障发育的关系
Compr Rev Food Sci Food Saf. 2019 Jan;18(1):121-139. doi: 10.1111/1541-4337.12400. Epub 2018 Oct 25.
2
More than sugar in the milk: human milk oligosaccharides as essential bioactive molecules in breast milk and current insight in beneficial effects.不仅是牛奶中的糖:人乳寡糖作为母乳中的必需生物活性分子及有益作用的最新认识
Crit Rev Food Sci Nutr. 2021;61(7):1184-1200. doi: 10.1080/10408398.2020.1754756. Epub 2020 Apr 24.
3
Human Milk Oligosaccharides Differently Modulate Goblet Cells Under Homeostatic, Proinflammatory Conditions and ER Stress.
Arch Microbiol. 2024 Aug 14;206(9):378. doi: 10.1007/s00203-024-04104-2.
4
Butyrate interacts with the effects of 2'FL and 3FL to modulate ovalbumin-induced immune activation, and 2'FL lowers mucosal mast cell activation in a preclinical model for hen's egg allergy.丁酸盐与2'-岩藻糖基乳糖(2'FL)和3-岩藻糖基乳糖(3FL)的作用相互影响,以调节卵清蛋白诱导的免疫激活,并且在鸡蛋过敏的临床前模型中,2'FL可降低黏膜肥大细胞的激活。
Front Nutr. 2023 Dec 19;10:1305833. doi: 10.3389/fnut.2023.1305833. eCollection 2023.
5
Lactational and geographical variation in the concentration of six oligosaccharides in Chinese breast milk: a multicenter study over 13 months postpartum.中国母乳中六种低聚糖浓度的泌乳期和地域差异:一项产后13个月的多中心研究
Front Nutr. 2023 Sep 5;10:1267287. doi: 10.3389/fnut.2023.1267287. eCollection 2023.
6
Epithelial-derived galectin-9 containing exosomes contribute to the immunomodulatory effects promoted by 2'-fucosyllactose and short-chain galacto- and long-chain fructo-oligosaccharides.上皮细胞来源的含有半乳糖凝集素-9 的外泌体有助于 2'-岩藻糖基乳糖和短链半乳糖和长链果糖低聚糖促进的免疫调节作用。
Front Immunol. 2022 Dec 22;13:1026031. doi: 10.3389/fimmu.2022.1026031. eCollection 2022.
7
Recent Research and Application Prospect of Functional Oligosaccharides on Intestinal Disease Treatment.功能性寡糖在肠道疾病治疗中的研究现状与应用前景
Molecules. 2022 Nov 7;27(21):7622. doi: 10.3390/molecules27217622.
8
The Manifold Bioactivity and Immunoreactivity of Microbial Proteins of Cow and Human Mature Milk in Late Lactation.奶牛和人类晚泌乳期成熟乳中微生物蛋白的多种生物活性和免疫反应性
Animals (Basel). 2022 Sep 28;12(19):2605. doi: 10.3390/ani12192605.
9
H NMR Metabolomics of Chinese Human Milk at Different Stages of Lactation among Secretors and Non-Secretors.哺乳期不同阶段中国母乳的 H NMR 代谢组学:分泌型和非分泌型个体的比较
Molecules. 2022 Aug 27;27(17):5526. doi: 10.3390/molecules27175526.
10
Variations in the Composition of Human Milk Oligosaccharides Correlates with Effects on Both the Intestinal Epithelial Barrier and Host Inflammation: A Pilot Study.人乳寡糖组成的变化与对肠道上皮屏障和宿主炎症的影响相关:一项初步研究。
Nutrients. 2022 Feb 28;14(5):1014. doi: 10.3390/nu14051014.
人乳寡糖在稳态、炎症前状态和内质网应激下对杯状细胞的调节作用不同。
Mol Nutr Food Res. 2020 Mar;64(5):e1900976. doi: 10.1002/mnfr.201900976. Epub 2019 Dec 11.
4
Human Milk Oligosaccharides Increase Mucin Expression in Experimental Necrotizing Enterocolitis.人乳寡糖可增加实验性坏死性小肠结肠炎黏蛋白的表达。
Mol Nutr Food Res. 2019 Feb;63(3):e1800658. doi: 10.1002/mnfr.201800658. Epub 2018 Dec 10.
5
The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and Beyond.肿瘤坏死因子(TNF)家族配体和受体:免疫系统内外的通讯模块。
Physiol Rev. 2019 Jan 1;99(1):115-160. doi: 10.1152/physrev.00045.2017.
6
Human Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula.人乳寡糖:婴儿配方奶粉中的 2'-岩藻糖基乳糖(2'-FL)和乳-N-新四糖(LNnT)。
Nutrients. 2018 Aug 24;10(9):1161. doi: 10.3390/nu10091161.
7
Innate Immunity of Neonates and Infants.新生儿和婴儿的固有免疫。
Front Immunol. 2018 Jul 30;9:1759. doi: 10.3389/fimmu.2018.01759. eCollection 2018.
8
A New Venue of TNF Targeting.TNF 靶向治疗的新途径。
Int J Mol Sci. 2018 May 11;19(5):1442. doi: 10.3390/ijms19051442.
9
Mother's Milk: A Purposeful Contribution to the Development of the Infant Microbiota and Immunity.母乳:对婴儿微生物组和免疫发育的有益贡献。
Front Immunol. 2018 Feb 28;9:361. doi: 10.3389/fimmu.2018.00361. eCollection 2018.
10
Overcoming the limited availability of human milk oligosaccharides: challenges and opportunities for research and application.克服人乳寡糖供应有限的问题:研究与应用面临的挑战和机遇
Nutr Rev. 2016 Oct;74(10):635-44. doi: 10.1093/nutrit/nuw025.